FDA Set to Review Moderna’s mFlusiva mRNA Flu Shot
An mRNA (messenger ribonucleic acid) influenza biologic developed by Moderna, Inc. is scheduled to be reviewed today by a U.S. Food and Drug Administration (FDA) advisory panel. The Vaccines and Related Biological Products Advisory Committee ((VRBPAC) will evaluate data on Moderna’s mFlusiva (formerly known as mRNA-1010) to determine if the product provides superior relative vaccine […]
Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]
American College of Obstetricians and Gynecologists Withdraws from ACIP
The American College of Obstetricians and Gynecologists (ACOG) recently announced its withdrawal as a liaison organization from the U.S. Center for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). The Association cited recent changes that have been made to the new ACIP committee, which the medical trade organization alleges undermines scientific integrity […]
Government Expands U.S. Glyphosate Production and Liability Protections
President Trump issued an Executive Order on Feb. 18, 2026 prioritizing domestic production of glyphosate, the primary ingredient in the herbicide Roundup, calling it critical to national security. Glyphosate has been the subject of extensive litigation in recent years and has been classified as “probably carcinogenic to humans” by some international health agencies, including the […]
Female Physicians Experience Increasing Rates of Isolation, Burnout and Suicide Risk
The societal aftershocks of the COVID-19 pandemic continue to surface in ways that extend beyond infection and mortality statistics, with one sector in particular yet to rebound after carrying much of the pandemic’s burden: U.S. health care. A large national study published in Mayo Clinic Proceedings now adds social isolation as a measurable and consequential […]
Use of Vaccination Metrics in Physician Payment Programs Discouraged by CMS
A new State Health Official (SHO) letter from the Centers for Medicare & Medicaid Services (CMS)—the federal agency that oversees Medicaid and sets quality and payment standards for state health programs nationwide—provides new federal guidance that challenges a long-standing federal policy financially incentivizing physicians to vaccinate their patients, particularly children.1 CMS announced on Dec. 30, […]